Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Saisei Ventures is a venture capital firm founded by biotechnology veterans and investors, established to enhance the Japanese biotech ecosystem. The firm connects Japanese research with global expertise to improve patient outcomes through innovative solutions. Founded in Japan, Saisei Ventures operates with a bi-regional approach, maintaining offices in both Cambridge, USA, and Tokyo, Japan. This strategic positioning allows the firm to tap into both local and international biotech markets.
Currently, Saisei Ventures manages a focused portfolio of seven companies, emphasizing its commitment to the life sciences sector. The firm is recognized for its hands-on approach, actively participating in the creation of companies rather than merely investing. This model positions Saisei Ventures as a leader in the Japanese biotech landscape, aiming to address serious diseases through transformative biotech advancements.
Saisei Ventures specializes in the life sciences sector, particularly in advanced therapeutic platforms such as cell immunotherapies, pluripotent cell replacement therapies, and gene therapy approaches. The firm invests in programs that demonstrate a clear path to clinical and commercial scale manufacturing. This focus on advanced modalities allows Saisei Ventures to support innovative solutions that address serious diseases, leveraging the strengths of the Japanese ecosystem while sourcing technologies globally.
The firm primarily targets seed to early clinical stage investments, emphasizing proof of concept to Investigational New Drug (IND) stages. Saisei Ventures seeks to combine Western expertise with Japanese innovation, aiming to build globally competitive companies that improve patient health outcomes. Their investment strategy is designed to harness Japan's rich research environment, which has historically been underserved by venture capital.
Saisei Ventures partners with a select group of innovative companies in the biotech sector. The current portfolio includes:
This diverse portfolio reflects Saisei Ventures' commitment to advancing healthcare through innovative biotech solutions.
Dr. Sven Kili: Partner at Saisei Ventures, Dr. Kili has a background in medicine and extensive experience in the biotechnology sector. He has previously worked with leading biotech firms and has been involved in numerous successful investments and company formations. His expertise lies in identifying promising biotech innovations and guiding them through the investment process.
To pitch to Saisei Ventures, founders should use the email address ideas@saiseiventures.com. The pitch deck should include a comprehensive overview of the business, including the problem being addressed, the solution offered, market analysis, competitive landscape, and team qualifications. Saisei Ventures values clarity and detail in presentations.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, but cold emails are also accepted if they are well-crafted and informative.
Saisei Ventures runs the Bridge-to-Biotech initiative, aimed at helping Japanese scientists translate their discoveries into venture-ready biotech companies. Additionally, they announced the Executive Fellows Program in April 2025, designed to enhance Japan's biotech leadership pipeline.
As of April 2025, Saisei Ventures announced the launch of its Executive Fellows Program, aimed at enhancing Japan's biotech leadership pipeline. This initiative reflects the firm's commitment to fostering talent within the Japanese biotech ecosystem.
Additionally, Saisei Ventures continues to expand its portfolio, focusing on innovative companies that align with its investment thesis in advanced therapeutic platforms.
What are Saisei Ventures' investment criteria?
Saisei Ventures focuses on the life sciences sector, particularly advanced therapeutic platforms. They invest in seed to early clinical stage companies that demonstrate a clear path to clinical and commercial scale manufacturing.
How can I apply or pitch to Saisei Ventures?
Founders can pitch their ideas by sending an email to ideas@saiseiventures.com. It is recommended to include a detailed overview of the business model, market opportunity, and team background in the pitch.
What makes Saisei Ventures different from other VC firms?
Saisei Ventures combines Western expertise with Japanese innovation, actively participating in company creation rather than just investing. This hands-on approach allows them to bridge the gap between Japanese scientific innovation and global biotech markets.
What is the geographic scope of Saisei Ventures?
The firm primarily focuses on Japan but also invests in companies based in the United States and Canada, reflecting its bi-regional investment strategy.
What is the typical check size for investments?
Specific check sizes are not publicly disclosed, but Saisei Ventures typically invests in early-stage companies, which may suggest smaller initial investments compared to later-stage funding.
What kind of post-investment involvement can portfolio companies expect?
Saisei Ventures takes an active role in the development of its portfolio companies, providing operational support, mentorship, and access to their extensive network in both Japan and the global biotech community.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.